In 1978, together with Gordon H. Burgess, Professor Schwartz first described florid cutaneous papillomatosis, a paraneoplastic disorder that has since been renamed as the Schwartz-Burgess syndrome. In 1980, Schwartz and Lasker Award winner Edmund Klein published pioneering work presenting the first effective treatment of Kaposi's sarcoma. In 1981, Schwartz headed one of the three teams that first described AIDS-associated Kaposi's sarcoma. Little was known of AIDS, the then-mysterious epidemic that was fast becoming the deadliest in history. That same year, Professor Schwartz first described the acral acanthotic anomaly, also known as acral acanthosis nigricans. Much more was described in his six books and more than a dozen monographs, 300 book chapters, 550 articles, and 250 other publications. In 2012, he reevaluated and renamed as solar cheilosis the most common precursor to lip cancer. In 2015, he published two articles reiterating the value of vaccination for human papillomavirus infection in preventing a variety of cancers.
Professor Schwartz research has brought him worldwide recognition as well as numerous honors for his seminal contributions to medicine, including the title of Doctor of Science, honoris causa, at the Tbilisi Medical Academy and Honorary Professor at the China Medical University and the Sree Balaji Medical College in Chennai. He has been elected as an honorary member of more than
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